Skip to main content
. 2019 May 28;9:7960. doi: 10.1038/s41598-019-44478-8

Figure 4.

Figure 4

The biomedical applications of PGS-M-n-HA-0.4, PGS-M-n-HA-0.5, and PGS-M-n-HA-0.6 composite scaffolds in bone regeneration in vitro. (A) the effects of these scaffolds on cell proliferation in human adipose-derived stem cells (hADSCs); (B) the expression levels of proinflammatory factor IL-6, and the expression levels of genes associated with osteoblast differentiation by qRT-PCR; The levels of RUNX2, OCN proteins by western blot (C) and immunohistochemical staining (D).